VeriStar Capital Management LP Has $6.09 Million Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

VeriStar Capital Management LP boosted its stake in Molina Healthcare, Inc. (NYSE:MOH) by 7.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,913 shares of the company’s stock after acquiring an additional 1,460 shares during the period. Molina Healthcare accounts for about 10.2% of VeriStar Capital Management LP’s holdings, making the stock its 5th biggest position. VeriStar Capital Management LP’s holdings in Molina Healthcare were worth $6,087,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MOH. Norges Bank bought a new stake in Molina Healthcare in the 4th quarter valued at about $134,675,000. FMR LLC increased its stake in shares of Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company’s stock worth $524,214,000 after purchasing an additional 427,276 shares in the last quarter. Invesco Ltd. raised its position in shares of Molina Healthcare by 28.5% in the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company’s stock valued at $386,229,000 after purchasing an additional 294,180 shares during the period. Wellington Management Group LLP lifted its stake in shares of Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company’s stock valued at $766,111,000 after buying an additional 181,073 shares in the last quarter. Finally, Los Angeles Capital Management LLC boosted its holdings in Molina Healthcare by 166.1% in the 4th quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company’s stock worth $57,195,000 after buying an additional 122,674 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now directly owns 17,375 shares of the company’s stock, valued at $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.10% of the company’s stock.

Molina Healthcare Stock Performance

NYSE MOH opened at $314.69 on Friday. The company has a fifty day moving average of $319.39 and a 200-day moving average of $307.68. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $365.23. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The company has a market capitalization of $17.21 billion, a P/E ratio of 15.40, a P/E/G ratio of 1.06 and a beta of 0.70.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.86 by $0.22. The firm had revenue of $11.15 billion during the quarter, compared to analysts’ expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. During the same period in the prior year, the business earned $5.73 EPS. As a group, equities research analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have issued reports on MOH. Stephens reissued an “equal weight” rating and set a $345.00 target price on shares of Molina Healthcare in a report on Thursday, February 6th. Barclays raised their target price on Molina Healthcare from $339.00 to $362.00 and gave the stock an “equal weight” rating in a research note on Friday. Mizuho upped their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. UBS Group cut their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research report on Friday, February 7th. Finally, Robert W. Baird reaffirmed a “neutral” rating and set a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Nine research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $365.38.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.